Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,267.30
-5.80 (-0.26%)
Jun 16, 2026, 10:45 AM IST
Lupin Market Cap
Lupin has a market cap or net worth of 1.04 trillion as of June 15, 2026. Its market cap has increased by 15.57% in one year.
Market Cap
1.04T
Enterprise Value
1.01T
Revenue
279.58B
Ranking
n/a
PE Ratio
19.49
Stock Price
2,267.30
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 1.04T, an increase of 104,041.91%. That is a compound annual growth rate of 29.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.04T | 7.75% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.76T |
| Cipla | 1.12T |
| Zydus Lifesciences | 1.11T |
| Mankind Pharma | 982.99B |
| Aurobindo Pharma | 847.42B |
| Laurus Labs | 752.72B |
| Alkem Laboratories | 633.46B |
| Glenmark Pharmaceuticals | 613.45B |